Literature DB >> 23523699

Expression and purification of active receptor interacting protein 1 kinase using a baculovirus system.

Jenny L Maki1, J Tres Brazell, Xin Teng, Gregory D Cuny, Alexei Degterev.   

Abstract

Receptor Interacting Protein 1 (RIP1) kinase is one of the key mediators of tumor necrosis factor alpha (TNF-α) signaling and is critical for activation of necroptotic cell death. We developed a method for expression of recombinant kinase, utilizing baculovirus co-infection of Cdc37, an Hsp90 co-chaperone, and RIP1-His, followed by a two-step purification scheme. After optimization, 1-3mg of highly purified RIP1 kinase was typically obtained from a 1L of Sf9 cells. The recombinant protein displayed kinase activity that was blocked by RIP1 inhibitors, necrostatins. The purified protein was used to develop a simple and robust thermal shift assay for further assessment of RIP1 inhibitors.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23523699      PMCID: PMC3653991          DOI: 10.1016/j.pep.2013.03.002

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  24 in total

1.  High-density miniaturized thermal shift assays as a general strategy for drug discovery.

Authors:  M W Pantoliano; E C Petrella; J D Kwasnoski; V S Lobanov; J Myslik; E Graf; T Carver; E Asel; B A Springer; P Lane; F R Salemme
Journal:  J Biomol Screen       Date:  2001-12

2.  Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.

Authors:  Paul T C Wan; Mathew J Garnett; S Mark Roe; Sharlene Lee; Dan Niculescu-Duvaz; Valerie M Good; C Michael Jones; Christopher J Marshall; Caroline J Springer; David Barford; Richard Marais
Journal:  Cell       Date:  2004-03-19       Impact factor: 41.582

3.  Structure-activity relationship study of novel necroptosis inhibitors.

Authors:  Xin Teng; Alexei Degterev; Prakash Jagtap; Xuechao Xing; Sungwoon Choi; Régine Denu; Junying Yuan; Gregory D Cuny
Journal:  Bioorg Med Chem Lett       Date:  2005-11-15       Impact factor: 2.823

4.  Time reduction and process optimization of the baculovirus expression system for more efficient recombinant protein production in insect cells.

Authors:  Björn Philipps; Daniel Rotmann; Micha Wicki; Lorenz M Mayr; Michael Forstner
Journal:  Protein Expr Purif       Date:  2005-04-09       Impact factor: 1.650

5.  Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury.

Authors:  Alexei Degterev; Zhihong Huang; Michael Boyce; Yaqiao Li; Prakash Jagtap; Noboru Mizushima; Gregory D Cuny; Timothy J Mitchison; Michael A Moskowitz; Junying Yuan
Journal:  Nat Chem Biol       Date:  2005-05-29       Impact factor: 15.040

6.  RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death.

Authors:  B Z Stanger; P Leder; T H Lee; E Kim; B Seed
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

Review 7.  Signal transduction by tumor necrosis factor receptors.

Authors:  Lucía Cabal-Hierro; Pedro S Lazo
Journal:  Cell Signal       Date:  2012-02-20       Impact factor: 4.315

8.  The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways.

Authors:  Zhigao Wang; Hui Jiang; She Chen; Fenghe Du; Xiaodong Wang
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

9.  Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation.

Authors:  J Lewis; A Devin; A Miller; Y Lin; Y Rodriguez; L Neckers; Z G Liu
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

10.  Fluorescence polarization assay for inhibitors of the kinase domain of receptor interacting protein 1.

Authors:  Jenny L Maki; Elizabeth E Smith; Xin Teng; Soumya S Ray; Gregory D Cuny; Alexei Degterev
Journal:  Anal Biochem       Date:  2012-05-29       Impact factor: 3.365

View more
  3 in total

1.  A cytosolic heat shock protein 90 and cochaperone CDC37 complex is required for RIP3 activation during necroptosis.

Authors:  Dianrong Li; Tao Xu; Yang Cao; Huayi Wang; Lin Li; She Chen; Xiaodong Wang; Zhirong Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-07       Impact factor: 11.205

2.  Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1.

Authors:  Malek Najjar; Chalada Suebsuwong; Soumya S Ray; Roshan J Thapa; Jenny L Maki; Shoko Nogusa; Saumil Shah; Danish Saleh; Peter J Gough; John Bertin; Junying Yuan; Siddharth Balachandran; Gregory D Cuny; Alexei Degterev
Journal:  Cell Rep       Date:  2015-03-24       Impact factor: 9.423

3.  Evaluation of RIP1K and RIP3K expressions in the malignant and benign breast tumors.

Authors:  Fatemeh Karami-Tehrani; Amin Rahimi Malek; Zahra Shahsavari; Morteza Atri
Journal:  Tumour Biol       Date:  2016-01-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.